Proton pump inhibitors (PPIs), a popular class of heartburn drugs, are linked to stomach cancer, a recent review found.
The review indicates that prolonged use of PPIs—exceeding three months—“is significantly associated with an elevated risk of cancer,” while shorter-term usage “appears to pose a comparatively lower risk,” the authors wrote.
